drug · Product Intelligence

Docetaxel
Pipeline Intelligence

Docetaxel: 4 indexed trials, 1 sponsors; 0 linked Orange Book patents and 7 FDA-linked events where matched.

⚗
4Indexed trials
▦
1Sponsors
⌁
0Orange Book patent links
◎
7FDA-linked events

Development evidence

NCT02564263Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT03221426Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT03834506Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT06952504Merck Sharp & Dohme LLC · parkinsonsPHASE3

FDA / patent evidence

Orange Book match found; no listed patent relation was retained for this product match.

Regulatory context

FDA_APPROVALDOCETAXEL · 2021-01-14
FDA_APPROVALDOCETAXEL · 2019-05-16
FDA_APPROVALDOCETAXEL · 2018-08-24
FDA_APPROVALDOCETAXEL · 2018-01-19
FDA_APPROVALDOCETAXEL · 2017-01-20
FDA_APPROVALDOCETAXEL · 2013-04-12
FDA_APPROVALDOCETAXEL · 2011-06-29

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.